InSilico Medicine Cayman TopCo
13.98
USD
-2.07
(-12.90%)
Important Dates
INSILICO MEDICINE CAYMAN TOPCO's next confirmed earnings release is scheduled for March 29, 2027.
| Earnings Date | 3/29/2027 |
Share Statistics
As of June 30, 2026, INSILICO MEDICINE CAYMAN TOPCO has 202.54M shares outstanding.
| Shares Outstanding | 202.54M |
Financial Position
As of June 30, 2026, INSILICO MEDICINE CAYMAN TOPCO maintains a current ratio of 8.70, meaning it holds 8.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 8.70 |
| Quick Ratio | 8.47 |
| Debt / Equity | 3.59 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 317.00 |
Balance Sheet
USDAs of June 30, 2026, INSILICO MEDICINE CAYMAN TOPCO holds 584.82M in cash and equivalents against 19.66M in total debt, resulting in a net debt position of -342.93M. Total book value stands at 547.06M, with working capital of 532.01M providing operational flexibility.
| Cash & Cash Equivalents | 584.82M |
| Total Debt | 19.66M |
| Net Debt | -342.93M |
| Equity (Book Value) | 547.06M |
| Book Value Per Share | 2.70 |
| Working Capital | 532.01M |